Neoprobe Corporation Announces Renewal Of Marketing Agreement With Ethicon Endo-Surgery, Inc.

DUBLIN, Ohio--(BUSINESS WIRE)--March 13, 2006--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that it had received notification of the renewal its Marketing and Distribution Agreement with Ethicon Endo-Surgery, Inc., through December 2008. Ethicon Endo-Surgery has distributed the Company's neo2000(R) gamma detection system on a worldwide basis, except Japan, since 1999.

Back to news